The 10th Annual American Society of Microbiology (ASM) Biodefense and Emerging Diseases Research Meeting will begin this Sunday February 26, 2012. The meeting will gather more than an estimated 1,000 participants from academia, government and industry focused on research, countermeasure development and issues for biological agents and emerging threats. Key topics include:
- Persistence and inactivation of biothreat agents and emerging pathogens
- Environmental detection methodologies
- Emerging foodborne illnesses
- H5N1 Research
- Immunity to Pulmonary Pathogens
- Animal Models in Biodefense Research
- Biodefense Implications of Vector-Borne Infections
- Biological Weapons Convention (BWC) Conference review
- Targeting Virulence Factors in Acute Infections
- Immune Response, Therapeutics, Diagnostics and Vaccines presentations
- Genetic Resistance to Infections
- Visual Discovery of Microbe-Host Interactions
- Non-coding RNAs and regulation of virulence
Featured speakers scheduled to address are: Dr. Alan Rudolph, Director for Chemical and Biological Technologies Directorate, Defense Threat Reduction Agency (DTRA); Assistant Secretary Thomas Countryman, U.S. Department of State Bureau of International Security and Nonproliferation; Paul A. Offit, MD, The Children’s Hospital of Philadelphia, PA; Michael T. Osterholm, Ph.D., University of Minnesota School of Public Health, Minneapolis, MN Director, Center for Infectious Disease Research and Policy (CIDRAP); Anthony S. Fauci, M.D. Director, National Institute of Allergy and Infectious Diseases (NIAID); Bruce Alberts, Ph.D. Editor-in-Chief of Science. Access the ASM Biodefense 2012 website for a complete agenda and list of exhibitors.
The conference runs from February 27-29, 2012 and does allow same day on-site registration. ASM is also offering free live streaming or recorded viewing of the H5N1 panel discussion scheduled for the morning of February 29th.
Visit the Global Biodefense Events page for additional conference listings for 2012.
